United States · FDA National Drug Code directory
FOTIVDA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45629-089_40222ff4-0ffc-318f-e063-6294a90aadc2
- Product NDC
- 45629-089
- Form
- CAPSULE
- Composition / generic term
- Tivozanib
- Labeler
- AVEO Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210310
- Source listing expiry
- 20261231
Source-listed ingredients
- TIVOZANIB HYDROCHLORIDE — .89 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 BAG (45629-089-01) / 21 CAPSULE in 1 BOTTLE, PLASTIC · 45629-089-01
- 1 BOTTLE, PLASTIC in 1 CARTON (45629-089-02) / 21 CAPSULE in 1 BOTTLE, PLASTIC · 45629-089-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →